Federal Circuit denies Illumina’s writ request in Ariosa dispute


The US Court of Appeals for the Federal Circuit has said it won’t review a writ filed by Illumina and its subsidiary Verinata Health in a patent dispute with Ariosa Diagnostics.

Federal circuit, petition, IPR, patent, Illumina, Verinata, Ariosa, Roche

More on this story

Illumina handed $27m in prenatal patent win